Weisheng Deng
Overview
Explore the profile of Weisheng Deng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
37
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li J, Chen Y, Deng W, Zeng J
Clin Case Rep
. 2024 Jan;
12(2):e8450.
PMID: 38292218
Key Clinical Message: Aspirin-related hemolysis in G6PD deficiency could be late-onset during long-term administration. Hemolytic anemia could continue for a relatively long time in elder patient with G6PD deficiency, which...
2.
Liu Q, Deng W, Guo X, Li K
Microb Pathog
. 2023 Jul;
182:106267.
PMID: 37482114
it was to explore the mechanism of Japanese encephalitis virus (JEV) and micro ribonucleic acid (miRNA) under high-throughput sequencing. 20 experimental mice, with good growth status and no disease infection,...
3.
Wang A, Jia B, Zhang X, Huo X, Chen J, Gui L, et al.
JAMA Neurol
. 2023 Jun;
80(8):851-859.
PMID: 37358859
Importance: DL-3-n-butylphthalide (NBP) is a drug for treating acute ischemic stroke and may play a neuroprotective role by acting on multiple active targets. The efficacy of NBP in patients with...
4.
Li J, Chen Y, Ou Z, Zhang Y, Liang Z, Deng W, et al.
Eur J Neurol
. 2022 May;
29(9):2683-2689.
PMID: 35608963
Background And Purpose: Intracranial atherosclerotic stenosis (ICAS) is a major cause of stroke in Asian countries. Glucose-6-phosphate dehydrogenase (G6PD) deficiency, a hereditary enzyme defect prevalent in Asian countries, has been...
5.
Chen Y, Li J, Ou Z, Zhang Y, Liang Z, Deng W, et al.
CNS Neurosci Ther
. 2021 Aug;
27(10):1206-1213.
PMID: 34369077
Aims: The risk of hemoglobin decline induced by low-dose aspirin in glucose-6-phosphate dehydrogenase (G6PD) deficiency remains unknown, and its influence on stroke outcome remains to be investigated. This study aimed...
6.
Chen Y, Li J, Ou Z, Zhang Y, Liang Z, Deng W, et al.
Int J Stroke
. 2020 Sep;
16(4):411-419.
PMID: 32878589
Background And Purpose: Aspirin is the first recommended antiplatelet agent to prevention secondary stroke, but its safety and efficacy in stroke patients with glucose-6-phosphate dehydrogenase deficiency remain unclear. We sought...
7.
Ou Z, Chen Y, Li J, Ouyang F, Liu G, Tan S, et al.
Neurology
. 2020 Jul;
95(11):e1471-e1478.
PMID: 32651291
Objective: To assess the risk of glucose-6-phosphate dehydrogenase (G6PD) on stroke prognosis, we compared outcomes between patients with stroke with and without G6PD deficiency. Methods: The study recruited 1,251 patients...